Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Primus E Mullis

Showing results (91-100 of 97) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 97 results.
Plos One|November 19, 2015
Human MAMLD1 Gene Variations Seem Not Sufficient to Explain a 46,XY DSD PhenotypeNúria Camats, Mónica Fernández-Cancio, Laura Audí, et al.
American Journal of Epidemiology|April 13, 2012
Growth hormone receptor polymorphism and growth hormone therapy response in children: a Bayesian meta-analysisAndrew G Renehan, Mattea Solomon, Marcel Zwahlen, et al.
Pediatric Diabetes|January 5, 2006
A cross-sectional international survey of continuous subcutaneous insulin infusion in 377 children and adolescents with type 1 diabetes mellitus from 10 countriesThomas Danne, Tadej Battelino, Olga Kordonouri, et al.
The Journal of Clinical Endocrinology and Metabolism|July 2, 2009
Expanding the spectrum of mutations in GH1 and GHRHR: genetic screening in a large cohort of patients with congenital isolated growth hormone deficiencyKyriaki S Alatzoglou, James P Turton, Daniel Kelberman, et al.
The Journal of Clinical Endocrinology and Metabolism|February 11, 2017
Cancer Risks in Patients Treated With Growth Hormone in Childhood: The SAGhE European Cohort StudyAnthony J Swerdlow, Rosie Cooke, Dominique Beckers, et al.
Hormone Research in Paediatrics|August 1, 2015
Description of the SAGhE Cohort: A Large European Study of Mortality and Cancer Incidence Risks after Childhood Treatment with Recombinant Growth HormoneAnthony J Swerdlow, Rosie Cooke, Kerstin Albertsson-Wikland, et al.
Nature Genetics|March 10, 2015
De novo loss- or gain-of-function mutations in KCNA2 cause epileptic encephalopathySteffen Syrbe, Ulrike B S Hedrich, Erik Riesch, et al.
Pageof 10

Showing results (91-100 of 97) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 97 results.
Plos One|November 19, 2015
Human MAMLD1 Gene Variations Seem Not Sufficient to Explain a 46,XY DSD PhenotypeNúria Camats, Mónica Fernández-Cancio, Laura Audí, et al.
American Journal of Epidemiology|April 13, 2012
Growth hormone receptor polymorphism and growth hormone therapy response in children: a Bayesian meta-analysisAndrew G Renehan, Mattea Solomon, Marcel Zwahlen, et al.
Pediatric Diabetes|January 5, 2006
A cross-sectional international survey of continuous subcutaneous insulin infusion in 377 children and adolescents with type 1 diabetes mellitus from 10 countriesThomas Danne, Tadej Battelino, Olga Kordonouri, et al.
The Journal of Clinical Endocrinology and Metabolism|July 2, 2009
Expanding the spectrum of mutations in GH1 and GHRHR: genetic screening in a large cohort of patients with congenital isolated growth hormone deficiencyKyriaki S Alatzoglou, James P Turton, Daniel Kelberman, et al.
The Journal of Clinical Endocrinology and Metabolism|February 11, 2017
Cancer Risks in Patients Treated With Growth Hormone in Childhood: The SAGhE European Cohort StudyAnthony J Swerdlow, Rosie Cooke, Dominique Beckers, et al.
Hormone Research in Paediatrics|August 1, 2015
Description of the SAGhE Cohort: A Large European Study of Mortality and Cancer Incidence Risks after Childhood Treatment with Recombinant Growth HormoneAnthony J Swerdlow, Rosie Cooke, Kerstin Albertsson-Wikland, et al.
Nature Genetics|March 10, 2015
De novo loss- or gain-of-function mutations in KCNA2 cause epileptic encephalopathySteffen Syrbe, Ulrike B S Hedrich, Erik Riesch, et al.
Pageof 10